Condition: BRCA1 and/or BRCA2 Variant Carriers · Ovarian Carcinoma · Fallopian Tube Carcinoma · Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
To determine the incidence and risk factors in the development of ovarian, fallopian tube, and peritoneal cancers in Japanese women carrying Breast Cancer Susceptibility Gene (BRCA)1/2 variants.
This description comes directly from the study's public registry record.
Akira Hirasawa, M.D., Ph.D. · +81-86-235-7436 · hir-aki45@umin.org
Always discuss trial participation with your own doctor first.
| Okayama University | Okayama, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03296826